Combination of SRC kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
Details for Australian Patent Application No. 2004263095 (hide)
International Classifications
Event Publications
2 February 2006 PCT application entered the National Phase
PCT publication WO2005/013983 Priority application(s): WO2005/013983
29 October 2009 Application Accepted
Published as AU-B-2004263095
25 February 2010 Standard Patent Sealed
3 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004263097-System and method for determining concentration of sterilant
2004263094-Programmed immune responses using a vaccination node
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser